![Staffan Nilsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Staffan Nilsson
No más puestos en curso
Perfil
Staffan Nilsson is the founder of Nanosep AB, which was founded in 2003.
Antiguos cargos conocidos de Staffan Nilsson.
Empresas | Cargo | Fin |
---|---|---|
Nanosep AB
![]() Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Nanosep AB
![]() Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | Commercial Services |
- Bolsa de valores
- Insiders
- Staffan Nilsson